New research shows that key proteins known for their ability to prevent viral infections by inducing cell death can also block certain bacterial infections without triggering the death of the host cells.
Rather than killing host cells infected by Listeria in the gastrointestinal tract, the RIPK3 and MLKL proteins recognize the chemical composition of the bacteria and MLKL binds to it, preventing the spread of Listeria while keeping the host cells alive.
"While we've shown that these proteins take on a different function in intestinal epithelial cells than they do in immune cells, we're still not sure how or why this differentiation occurs," said the co-corresponding author of a paper describing the research.
The researchers first used human intestinal cells to show that RIPK3-deficient cells were infected by Listeria while cells with RIPK3 had few such infections. The researchers then used mice to see if Listeria could reach mouse livers by invading intestinal cells. They found many Listeria in RIPK3-deficient mice but few Listeria in normal mice.
They then showed that RIPK3 and a protein that works with it, MLKL, were activated by the presence of Listeria. This protein-pathway activation inhibited Listeria replication, showing that the proteins effectively blunted Listeria.
Next, and most surprisingly, the researchers showed that the activation of RIPK3 and MLKL by Listeria did not result in cell death. Instead, MLKL proteins bound themselves to Listeria, stopping its spread.
"These proteins induce cell death to prevent certain infections, particularly in immune cells," the author said. "Inducing death of epithelial cells in the GI tract may cause removal of an important barrier to viruses and bacteria, so it's possible that these proteins recognize that killing these cells could make things worse instead of better."
Future research will attempt to understand how and why these proteins take different approaches - inducing cell death or not - to stave off bacteria in the GI tract, the researchers said.
https://news.ncsu.edu/2019/04/cell-killing-proteins-suppress-listeria-without-killing-cells/
http://jcb.rupress.org/content/early/2019/04/10/jcb.201810014
Latest News
Axonal transport impaired by the loss of methylation of huntingtin
Modular complement assemblies for mitigating inflammatory conditions
Classification scheme developed for newly identified multiple sclerosis-like disease
Ebola virus protein exploits human RNA to change shape
A novel genetic disorder with defective mitochondrial DNA repair identified
Other Top Stories
Alcohol treatment drug disulfiram helps obese mice lose weight, improve metabolic function
A new brain-sparing and weight loss amphetamine without side effects
Drug combination could eliminate side effects of once-popular diabetes treatment
Blood test could predict postpartum diabetes in women with gestational diabetes
The mechanism of development of diabetes and fatty liver
Protocols
Protocol for brain-wide or region-specific microglia depletion and repopulation in adult mice
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
Publications
Huntingtin-mediated axonal transport requires arginine methylation by PRMT6
The converging roles of Batten disease proteins in neurodegeneration and cancer
Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essent…
Chronic stress physically spares but functionally impairs innate-like invariant T cells
Evolution of DNA methylation in the human brain
Presentations
Axoplasmic transport
Neural Networks
MicroRNA
Multiple Sclerosis
BASIC PRINCIPLES OF IMMUNOTHERAPY
Posters
Lymphangiogenesis-inducing vaccines to treat melanomas
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE